Technical Report Palliative Care
Effect of low-dose aspirin on acute kidney injury among adults with type 2 diabetes

Effect of low-dose aspirin on acute kidney injury among adults with type 2 diabetes

Authors

Hugo Osei

Hugo Osei

Royal Melbourne Hospital, Cayman Islands

Ethan Kim

Ethan Kim

King Fahad Medical City, Cocos (Keeling) Islands

Clara Kowalski

Clara Kowalski

St Thomas' Hospital, Vatican City State (Holy See)

Freya Mensah

Freya Mensah

Hamad Medical Corporation, Algeria

Corresponding

Published

January 6, 2025

Paper ID

PAP-000286

Status

Published

DOI

10.65712/tmj.test000544

Effect of low-dose aspirin on acute kidney injury among adults with type 2 diabetes

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on low-dose aspirin. Methods: We conducted a retrospective cohort study across 7 centres between 2014 and 2022. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Residual confounding cannot be excluded.

Introduction

acute kidney injury remains a leading cause of avoidable harm among adults with type 2 diabetes. The cost of acute kidney injury to health systems is substantial.

Guidelines make only a weak recommendation on low-dose aspirin.

Practice around low-dose aspirin varies widely between centres. The cost of acute kidney injury to health systems is substantial.

Earlier studies of low-dose aspirin were small or single-centre. Guidelines make only a weak recommendation on low-dose aspirin.

Discussion

Strengths include the sample size and blinded outcome assessment. Future work should test low-dose aspirin in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.

Implementation will depend on staffing, cost and local protocols. These findings suggest that low-dose aspirin is associated with better acute kidney injury in adults with type 2 diabetes.

Conclusions

Low-dose aspirin should be considered for adults with type 2 diabetes to improve acute kidney injury.

References

1. Larsen P, Kowalski Z, et al. Delayed cord clamping and length of stay. Crit Care Med. 2011;232(3):867-1795.

2. Moreau Z, Kowalski M, et al. Machine-learning triage and glycaemic control. BMC Med. 2009;140(5):889-1525.

3. Moreau U, Rahman R, et al. Early enteral nutrition and length of stay. Lancet. 2014;44(11):643-1370.

4. Kowalski W, Nasser A, et al. Low-dose aspirin and glycaemic control. Pediatrics. 2017;353(8):792-1374.

5. Silva C, Kim X, et al. Continuous glucose monitoring and ventilator-free days. Pediatrics. 2010;397(8):706-1060.

6. Kim U, Zhang M, et al. Telemedicine follow-up and acute kidney injury. Ann Intern Med. 2017;91(4):431-1108.

7. Novak E, Yilmaz N, et al. Early enteral nutrition and surgical site infection. JAMA. 2023;326(11):39-1520.

Appendices

The statistical analysis plan is in the online supplement.

Materials and Methods

We conducted a retrospective cohort study across 7 centres between 2018 and 2025. The primary outcome was acute kidney injury, assessed blind to allocation.

Eligible participants were adults with type 2 diabetes. Analyses were adjusted for age, sex and baseline severity.

Results

744 participants were included (median age 66 years). Effects were consistent across prespecified subgroups. 446 participants were included (median age 34 years).

426 participants were included (median age 29 years). Serious adverse events were rare and similar between groups. 860 participants were included (median age 48 years).

GroupnEventsRate %
Centre A8031174.6
Centre B8611510.7
Intervention8772225.2
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Forest plot of acute kidney injury
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.81 (95% CI 0.27 to 0.72). The adjusted odds ratio was 0.81 (95% CI 0.45 to 0.89). acute kidney injury occurred in 20% of the intervention group versus 23% of controls.

Effects were consistent across prespecified subgroups.